Logo image of BRCC

BRC INC-A (BRCC) Stock Fundamental Analysis

NYSE:BRCC - New York Stock Exchange, Inc. - US05601U1051 - Common Stock - Currency: USD

1.86  -0.05 (-2.62%)

After market: 1.85 -0.01 (-0.54%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BRCC. BRCC was compared to 90 industry peers in the Food Products industry. Both the profitability and financial health of BRCC have multiple concerns. BRCC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BRCC has reported negative net income.
In the past year BRCC had a positive cash flow from operations.
In the past 5 years BRCC reported 4 times negative net income.
In multiple years BRCC reported negative operating cash flow during the last 5 years.
BRCC Yearly Net Income VS EBIT VS OCF VS FCFBRCC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

BRCC has a Return On Assets of -2.87%. This is in the lower half of the industry: BRCC underperforms 67.78% of its industry peers.
BRCC has a Return On Equity of -57.16%. This is in the lower half of the industry: BRCC underperforms 76.67% of its industry peers.
BRCC has a Return On Invested Capital (2.18%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.87%
ROE -57.16%
ROIC 2.18%
ROA(3y)-15.06%
ROA(5y)-11.02%
ROE(3y)-157.61%
ROE(5y)-148.77%
ROIC(3y)N/A
ROIC(5y)N/A
BRCC Yearly ROA, ROE, ROICBRCC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

The Operating Margin of BRCC (1.08%) is worse than 63.33% of its industry peers.
Looking at the Gross Margin, with a value of 39.54%, BRCC belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
In the last couple of years the Gross Margin of BRCC has remained more or less at the same level.
Industry RankSector Rank
OM 1.08%
PM (TTM) N/A
GM 39.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.28%
GM growth 5Y-1.09%
BRCC Yearly Profit, Operating, Gross MarginsBRCC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BRCC is destroying value.
BRCC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BRCC has more shares outstanding
BRCC has a better debt/assets ratio than last year.
BRCC Yearly Shares OutstandingBRCC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BRCC Yearly Total Debt VS Total AssetsBRCC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 2.23 indicates that BRCC is not a great score, but indicates only limited risk for bankruptcy at the moment.
BRCC has a Altman-Z score (2.23) which is comparable to the rest of the industry.
BRCC has a Debt/Equity ratio of 5.95. This is a high value indicating a heavy dependency on external financing.
BRCC's Debt to Equity ratio of 5.95 is on the low side compared to the rest of the industry. BRCC is outperformed by 91.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.95
Debt/FCF N/A
Altman-Z 2.23
ROIC/WACC0.26
WACC8.36%
BRCC Yearly LT Debt VS Equity VS FCFBRCC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

2.3 Liquidity

BRCC has a Current Ratio of 1.30. This is a normal value and indicates that BRCC is financially healthy and should not expect problems in meeting its short term obligations.
BRCC has a Current ratio of 1.30. This is in the lower half of the industry: BRCC underperforms 61.11% of its industry peers.
A Quick Ratio of 0.61 indicates that BRCC may have some problems paying its short term obligations.
With a Quick ratio value of 0.61, BRCC is not doing good in the industry: 67.78% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.61
BRCC Yearly Current Assets VS Current LiabilitesBRCC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

5

3. Growth

3.1 Past

BRCC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.00%, which is quite impressive.
Looking at the last year, BRCC shows a decrease in Revenue. The Revenue has decreased by -6.67% in the last year.
The Revenue has been growing by 36.67% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
Revenue 1Y (TTM)-6.67%
Revenue growth 3Y18.87%
Revenue growth 5Y36.67%
Sales Q2Q%-8.56%

3.2 Future

Based on estimates for the next years, BRCC will show a very strong growth in Earnings Per Share. The EPS will grow by 55.35% on average per year.
BRCC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.81% yearly.
EPS Next Y-2%
EPS Next 2Y25.5%
EPS Next 3Y25.99%
EPS Next 5Y55.35%
Revenue Next Year3.99%
Revenue Next 2Y7.49%
Revenue Next 3Y13.37%
Revenue Next 5Y12.81%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BRCC Yearly Revenue VS EstimatesBRCC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M
BRCC Yearly EPS VS EstimatesBRCC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2028 0 1 -1 2 3 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BRCC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BRCC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRCC Price Earnings VS Forward Price EarningsBRCC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80 -100

4.2 Price Multiples

61.11% of the companies in the same industry are cheaper than BRCC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 32.14
BRCC Per share dataBRCC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

BRCC's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.5%
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

BRCC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRC INC-A

NYSE:BRCC (5/21/2025, 8:04:01 PM)

After market: 1.85 -0.01 (-0.54%)

1.86

-0.05 (-2.62%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners52.7%
Inst Owner Change-1.18%
Ins Owners21.35%
Ins Owner Change2.92%
Market Cap396.46M
Analysts80
Price Target3.23 (73.66%)
Short Float %11.81%
Short Ratio9.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-169.6%
Min EPS beat(2)-292.16%
Max EPS beat(2)-47.04%
EPS beat(4)2
Avg EPS beat(4)-60.11%
Min EPS beat(4)-292.16%
Max EPS beat(4)56.43%
EPS beat(8)3
Avg EPS beat(8)-84.66%
EPS beat(12)5
Avg EPS beat(12)58.58%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-2.26%
Max Revenue beat(2)0.14%
Revenue beat(4)2
Avg Revenue beat(4)-3.65%
Min Revenue beat(4)-13.52%
Max Revenue beat(4)1.03%
Revenue beat(8)2
Avg Revenue beat(8)-3.76%
Revenue beat(12)3
Avg Revenue beat(12)-3.41%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-31.53%
EPS NQ rev (1m)-28.59%
EPS NQ rev (3m)-100%
EPS NY rev (1m)0%
EPS NY rev (3m)-77.78%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)-3.61%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)-2.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.03
P/FCF N/A
P/OCF 175.97
P/B 35.48
P/tB 36.61
EV/EBITDA 32.14
EPS(TTM)-0.09
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.01
OCFY0.57%
SpS1.8
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.87%
ROE -57.16%
ROCE 2.76%
ROIC 2.18%
ROICexc 2.24%
ROICexgc 2.25%
OM 1.08%
PM (TTM) N/A
GM 39.54%
FCFM N/A
ROA(3y)-15.06%
ROA(5y)-11.02%
ROE(3y)-157.61%
ROE(5y)-148.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.28%
GM growth 5Y-1.09%
F-Score5
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 5.95
Debt/FCF N/A
Debt/EBITDA 4.63
Cap/Depr 69.68%
Cap/Sales 1.86%
Interest Coverage 250
Cash Conversion 15.7%
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.61
Altman-Z 2.23
F-Score5
WACC8.36%
ROIC/WACC0.26
Cap/Depr(3y)385%
Cap/Depr(5y)505.49%
Cap/Sales(3y)6.39%
Cap/Sales(5y)6.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
EPS Next Y-2%
EPS Next 2Y25.5%
EPS Next 3Y25.99%
EPS Next 5Y55.35%
Revenue 1Y (TTM)-6.67%
Revenue growth 3Y18.87%
Revenue growth 5Y36.67%
Sales Q2Q%-8.56%
Revenue Next Year3.99%
Revenue Next 2Y7.49%
Revenue Next 3Y13.37%
Revenue Next 5Y12.81%
EBIT growth 1Y115.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year203.83%
EBIT Next 3Y76.49%
EBIT Next 5Y53.49%
FCF growth 1Y96.26%
FCF growth 3YN/A
FCF growth 5Y-2.7%
OCF growth 1Y102.28%
OCF growth 3YN/A
OCF growth 5Y22.26%